Skip to content
This GLP
Updated September 2026Says the price climbs

LevelsRx review

Two starting prices on a seller whose cost rises with the dose, and no ceiling published.

The verdict

LevelsRx publishes starting prices of $150 a month for semaglutide and $240 for tirzepatide, read August 2026. An oral liposomal liquid is offered alongside the injection.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
Dose pricing
Rises with dose
From
$150/mo
Prescription
Required
Compounded
Yes — not FDA-approved

LevelsRx sells both molecules. Semaglutide comes as an injection or an oral liposomal liquid. Both figures are starting prices.

  1. Who writes the prescription, and what do they see?

    A prescription precedes shipping. The pages name products. No clinician is described and no intake is documented.

    Two formats on one line is the structure here. Which one a buyer takes is not priced separately on the pages read.

  2. What happens when the dose goes up?

    The cost rises with the dose. What it rises to is not published. Direction without a destination is half an answer.

  3. What the price includes

    $150 and $240 are floors. Six months at them is $900 and $1,440 at best. A rising price makes both totals a minimum rather than an estimate. Ask what the figure is at a therapeutic dose.

  4. What it claims, and what it cites

    Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.

Where it holds up, and where it does not

  • Strength: An oral and an injectable option
  • Strength: Both molecules carry a figure
  • Strength: The rising price is on the record
  • Limitation: Both figures are starting prices
  • Limitation: The upper rungs are not published
  • Limitation: No milligram dose stated
  • Limitation: No state coverage list is recorded

What the evidence says about this kind of treatment

The assessment above is about LevelsRx. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A reader who wants the oral option and will ask what the ladder costs.
Wrong for
A reader who needs a settled monthly figure.

How LevelsRx compares

SellerWho it suitsGo
LevelUp RxReaders who want the billed total before committing to a termSee LevelUp Rx
LongevixxReaders wanting a flat rate in any state who ignore the anchorSee Longevixx
LVNG RXReaders who want a bundle and accept the figure is confirmed laterSee LVNG RX
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: Rehydra+ WellnessRejuve MedsRemedy MedsREMEViRemote PharmacyRenlo Health

Sponsored alternative

Synergy Rx

A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.

Check Synergy Rx availability →

Frequently asked

Does the price rise with the dose?
Yes, and what it rises to is not published. Ask before ordering.
What is the oral option?
A liposomal liquid semaglutide, offered alongside the injection.
Is $150 a rate?
No. It is a starting price on a line that scales with dose.
Is LevelsRx expensive compared with other GLP-1 telehealth sellers?
LevelsRx publishes a starting figure of $150/mo. Across the 137 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $184, which puts LevelsRx below the median, toward the cheaper end. The other 11 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Glenn TorresStandards editor · Reviewed and last verified September 2026

How this was assessed. The four questions above are answered from LevelsRx’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.